All News

2055 articles, sorted by publication time.

New Drugs and Clinical Trials · us

Crossing the Blood-Brain Barrier: FDA Approves First Treatment for Neurological Symptoms of Type 3 Gaucher Disease

Even after their organ disease has stabilized, patients with type 3 Gaucher disease may still face worsening balance and cognitive difficulties. The newly approved oral drug venglustat offers an option for this treatment gap, but the limits of efficacy evidence from a small trial and psychiatric safety risks also require careful attention.

Cancer and New Drugs · global

Opening the Door to Immunotherapy for Hard-to-Treat Colorectal Cancer: ADG126 Combination Enters Phase 1 Trial

City of Hope will test a masked CTLA-4 antibody in combination with a PD-1/VEGF bispecific antibody, first identifying a safe dose before exploring the addition of chemotherapy. No efficacy results have been announced for this study, and whether it can overcome treatment challenges in microsatellite-stable tumors remains a question for human data.

Precision Medicine · global

Blood Testing Connects Patients to New Breast Cancer Therapy: FDA Approves Companion Diagnostic for Wilserdly

After advanced breast cancer develops treatment resistance, genetic changes in the tumor may offer clues for the next treatment. FoundationOne Liquid CDx has been approved to identify patients eligible for combination therapy with Wilserdly, but negative test results and long-term survival benefits each leave questions that require clarification.